Maita H, Harada Y, Nagakubo D, Kitaura H, Ikeda M, Tamai K, Takahashi K, Ariga H, Iguchi-Ariga S M
Department of Molecular Biology, Hokkaido University, Kita-ku, Sapporo, Japan.
Eur J Biochem. 2000 Aug;267(16):5168-78. doi: 10.1046/j.1432-1327.2000.01585.x.
Protooncogene, pim-1, has been reported to be a predisposition for lymphomagenesis along with myc, and its protein product, Pim-1, has been shown to be a serine/threonine protein kinase, whose activity is involved in proliferation and differentiation of blood cells. The signal transduction pathways neither to nor from Pim-1, however, have been clarified. We have cloned a cDNA encoding a novel Pim-1 binding protein, PAP-1, comprising 213 amino acids with a basic amino-acid cluster near the C-terminus. PAP-1 was colocalized with Pim-1 in human HeLa cell nuclei. The in vitro binding assays using GST fusion proteins of the wild-type and various deletion mutants revealed that the whole molecule of Pim-1 is required for the binding activity to PAP-1 and that Pim-1 binds to the region from amino-acid numbers 1-147 of PAP-1, or to two segments in the region. The association of PAP-1 with Pim-1 was also shown in vivo in transfected cells. Furthermore, PAP-1 was phosphorylated in vitro by Pim-1, but not a kinase-negative Pim-1 mutant. The two serine residues of PAP-1 at amino acids 204 and 206 near the C-terminus were phosphorylated by Pim-1. PAP-1 is thus thought to be a target protein for Pim-1 kinase.
原癌基因pim-1已被报道与myc一样是淋巴瘤发生的一个易感因素,其蛋白质产物Pim-1已被证明是一种丝氨酸/苏氨酸蛋白激酶,其活性参与血细胞的增殖和分化。然而,与Pim-1相关的信号转导途径,无论是上游还是下游,都尚未明确。我们克隆了一个编码新型Pim-1结合蛋白PAP-1的cDNA,该蛋白由213个氨基酸组成,在C末端附近有一个碱性氨基酸簇。PAP-1与人HeLa细胞核中的Pim-1共定位。使用野生型和各种缺失突变体的GST融合蛋白进行的体外结合试验表明,Pim-1的整个分子对于与PAP-1的结合活性是必需的,并且Pim-1与PAP-1的1-147位氨基酸区域或该区域的两个片段结合。在转染细胞的体内实验中也显示了PAP-1与Pim-1的结合。此外,PAP-1在体外被Pim-1磷酸化,但不被激酶阴性的Pim-1突变体磷酸化。PAP-1在C末端附近的204和206位氨基酸的两个丝氨酸残基被Pim-1磷酸化。因此,PAP-1被认为是Pim-1激酶的靶蛋白。